211At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges.
Saved in:
| Title: | 211At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges. |
|---|---|
| Authors: | Levillain H; Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium. hugo.levillain@hubruxelles.be., Moës AR; IBA SA, RadioPharmaSolutions, Brussels, Belgium., Gameiro-Paris C; IBA SA, RadioPharmaSolutions, Brussels, Belgium., Abrunhosa A; Institute for Nuclear Sciences Applied to Health (ICNAS), University of Coimbra, Coimbra, Portugal., Deakin T; LabLogic Systems Limited, Sheffield, UK., Gebhart G; Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium., Herth MM; TetraKit Technologies ApS, University of Copenhagen, Copenhagen, Denmark.; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Gestin JF; Nantes Université, Inserm, CNRS, Université d'Angers, CRCI2NA, Nantes, France., Haddad F; GIP Arronax, Saint-Herblain, and Subatech, Nantes, France., Jensen AI; TetraKit Technologies ApS, University of Copenhagen, Copenhagen, Denmark., Bue RL; The Oncidium Foundation, Brussels, Belgium., Mikolajczak R; Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland., Otamendi A; Vicomtech, San Sebastian, Spain., Staunton-Mann K; LabLogic Systems Limited, Sheffield, UK., Tabury K; Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium., Flamen P; Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium. |
| Corporate Authors: | Accelerate.EU consortium |
| Source: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 May 29. Date of Electronic Publication: 2026 May 29. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42209820 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: <superscript>211</superscript>At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Levillain+H%22">Levillain H</searchLink>; Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium. hugo.levillain@hubruxelles.be.<br /><searchLink fieldCode="AU" term="%22Moës+AR%22">Moës AR</searchLink>; IBA SA, RadioPharmaSolutions, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Gameiro-Paris+C%22">Gameiro-Paris C</searchLink>; IBA SA, RadioPharmaSolutions, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Abrunhosa+A%22">Abrunhosa A</searchLink>; Institute for Nuclear Sciences Applied to Health (ICNAS), University of Coimbra, Coimbra, Portugal.<br /><searchLink fieldCode="AU" term="%22Deakin+T%22">Deakin T</searchLink>; LabLogic Systems Limited, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Gebhart+G%22">Gebhart G</searchLink>; Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Herth+MM%22">Herth MM</searchLink>; TetraKit Technologies ApS, University of Copenhagen, Copenhagen, Denmark.; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Gestin+JF%22">Gestin JF</searchLink>; Nantes Université, Inserm, CNRS, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Haddad+F%22">Haddad F</searchLink>; GIP Arronax, Saint-Herblain, and Subatech, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Jensen+AI%22">Jensen AI</searchLink>; TetraKit Technologies ApS, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Bue+RL%22">Bue RL</searchLink>; The Oncidium Foundation, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Mikolajczak+R%22">Mikolajczak R</searchLink>; Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland.<br /><searchLink fieldCode="AU" term="%22Otamendi+A%22">Otamendi A</searchLink>; Vicomtech, San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Staunton-Mann+K%22">Staunton-Mann K</searchLink>; LabLogic Systems Limited, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Tabury+K%22">Tabury K</searchLink>; Belgian Nuclear Research Centre (SCK CEN), Mol, Belgium.<br /><searchLink fieldCode="AU" term="%22Flamen+P%22">Flamen P</searchLink>; Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Accelerate%2EEU+consortium%22">Accelerate.EU consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101140988%22">European journal of nuclear medicine and molecular imaging</searchLink> [Eur J Nucl Med Mol Imaging] 2026 May 29. <i>Date of Electronic Publication: </i>2026 May 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Berlin%22">Springer-Verlag Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101140988 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1619-7089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216197070%22">16197070 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Nucl Med Mol Imaging <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42209820 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00259-026-07950-y Languages: – Code: eng Text: English Titles: – TitleFull: 211At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Levillain H – PersonEntity: Name: NameFull: Moës AR – PersonEntity: Name: NameFull: Gameiro-Paris C – PersonEntity: Name: NameFull: Abrunhosa A – PersonEntity: Name: NameFull: Deakin T – PersonEntity: Name: NameFull: Gebhart G – PersonEntity: Name: NameFull: Herth MM – PersonEntity: Name: NameFull: Gestin JF – PersonEntity: Name: NameFull: Haddad F – PersonEntity: Name: NameFull: Jensen AI – PersonEntity: Name: NameFull: Bue RL – PersonEntity: Name: NameFull: Mikolajczak R – PersonEntity: Name: NameFull: Otamendi A – PersonEntity: Name: NameFull: Staunton-Mann K – PersonEntity: Name: NameFull: Tabury K – PersonEntity: Name: NameFull: Flamen P IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 05 Text: 2026 May 29 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1619-7089 Titles: – TitleFull: European journal of nuclear medicine and molecular imaging Type: main |
| ResultId | 1 |